Acta Neuropathologica

, Volume 97, Issue 5, pp 481–490

The CD34 epitope is expressed in neoplastic and malformative lesions associated with chronic, focal epilepsies

  • I. Blümcke
  • K. Giencke
  • Eva Wardelmann
  • Stefan Beyenburg
  • Thomas Kral
  • Nanette Sarioglu
  • Torsten Pietsch
  • Helmut K. Wolf
  • Johannes Schramm
  • Christian E. Elger
  • Otmar D. Wiestler
Regular paper

Abstract

The etiology and pathogenesis of complex focal lesions associated with chronic, intractable epilepsy are largely unknown. Some data indicate that malformative changes of the central nervous system may preceed the development of gangliogliomas and other epilepsy-associated neoplasms. In the present immunhistochemical study, we have examined epilepsy-associated lesions for CD34, a stem cell marker transiently expressed during early neurulation. Surprisingly, most tissue samples from patients with chronic epilepsy (n = 262) revealed neural cells immunoreactive for CD34. Prominent immunoreactivity was detected in gangliogliomas (74%), low-grade astrocytomas (62%) and oligodendrogliomas (59%). Only 52% of non-neoplastic, malformative pathologies, such as glio-neuronal hamartias or hamartomas showed solitary or small clusters of CD34-immunoreactive cells. None of the adult control tissues (n = 22), none of the specimens obtained from the developing human brain (n = 44) and none of those tumor samples from patients without epilepsy (n = 63) contained CD34-immunoreactive neural cells. However, a malignant teratoma with microscopic features of early neural differentiation displayed a focal CD34-immunoreactive staining pattern. The majority of CD34-immunoreactive cells co-localized with S-100 protein and a small subpopulation was also immunoreactive for neuronal antigens. CD34 may, thus, represent a valuable marker for the diagnostic evaluation of neoplastic and/or malformative pathological changes in epilepsy patients. The CD34 immunoreactivity of these lesions indicates an origin from dysplastic or atypically differentiated neural precursors. Further studies may elucidate the functional significance of CD34 expression during the pathogenesis of epilepsy-related focal lesions as well as during neurogenesis.

Key words Stem cell Tumor Malformation Epilepsy Ganglioglioma 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag Berlin Heidelberg 1999

Authors and Affiliations

  • I. Blümcke
    • 1
  • K. Giencke
    • 1
  • Eva Wardelmann
    • 2
  • Stefan Beyenburg
    • 3
  • Thomas Kral
    • 4
  • Nanette Sarioglu
    • 5
  • Torsten Pietsch
    • 1
  • Helmut K. Wolf
    • 6
  • Johannes Schramm
    • 4
  • Christian E. Elger
    • 3
  • Otmar D. Wiestler
    • 1
  1. 1.Department of Neuropatholgoy, University of Bonn Medical Center, Sigmund-Freud Str. 25, D-53105 Bonn, Germany e-mail: umt908@uni-bonn.de, Tel.: +49-228-287-6603, Fax: +49-228-287-4331DE
  2. 2.Department of Pathology, University of Bonn Medical Center, Sigmund-Freud-Str. 25, D-53105 Bonn, GermanyDE
  3. 3.Department of Epileptology, University of Bonn Medical Center, Sigmund-Freud-Str. 25, D-53105 Bonn, GermanyDE
  4. 4.Department of Neurosurgery, University of Bonn Medical Center, Sigmund-Freud-Str. 25, D-53105 Bonn, GermanyDE
  5. 5.Department of Pediatric Pathology, Rudolph-Virchow Medical Center, Humboldt University Berlin, Augustenburger Platz 1, D-13353 Berlin, GermanyDE
  6. 6.Department of Pathology, University of Mainz Medical Center, Langenbeckstr. 1, D-55131 Mainz, GermanyDE

Personalised recommendations